第一单位:
Department of Critical Care Medicine, Jiangmen Central Hospital, Jiangmen, China.
作者:
Peng,Zhang [1]
;
Baoyi,Liu [2]
;
Weihao,Zheng [1]
;
Yantang,Chen [1]
;
Zhentao,Wu [1]
;
Yuting,Lu [1]
;
Jie,Ma [1]
;
Wenjie,Lu [2]
;
Mingzhu,Zheng [2]
;
Wanting,Wu [2]
;
Zijie,Meng [2]
;
Jinhua,Wu [3]
;
Yan,Zheng [4]
;
Xin,Zhang [5]
;
Shuang,Zhang [1]
;
Yanming,Huang [6]
作者单位:
Department of Critical Care Medicine, Jiangmen Central Hospital, Jiangmen, China.
[1]
Clinical Experimental Center, Jiangmen Key Laboratory of Clinical Biobanks and Translational Research, Jiangmen Central Hospital, Jiangmen, China.
[2]
Department of Clinical Laboratory, Jiangmen Central Hospital, Jiangmen, China.
[3]
Department of Research and Development, Guangdong Research Institute of Genetic Diagnostic and Engineering Technologies for Thalassemia, Hybribio Limited, Guangzhou, China.
[4]
Clinical Experimental Center, Jiangmen Key Laboratory of Clinical Biobanks and Translational Research, Jiangmen Central Hospital, Jiangmen, China.;Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan, China.;Collaborative Innovation Center for Antitumor Active Substance Research and Development, Guangdong Medical University, Zhanjiang, China.
[5]
Clinical Experimental Center, Jiangmen Key Laboratory of Clinical Biobanks and Translational Research, Jiangmen Central Hospital, Jiangmen, China.;Department of Respiratory and Critical Care Medicine, Jiangmen Central Hospital, Jiangmen, China.
[6]
DOI
10.3389/fmolb.2022.862570
PMID
35813824
发布时间
2022-07-16